CCIA
SANA icon

Campbell & Co Investment Adviser’s Sana Biotechnology SANA Stock Holding History

Campbell & Co Investment Adviser’s Portfolio SANA Stock Details SANA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-52,459
Closed -$525K – 1313
2024
Q1 		$525K Buy
+52,459
New +$393K 0.05% 669

Other funds holding SANA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Campbell & Co Investment Adviser's SANA Position: Q2 2024 in Review

Campbell & Co Investment Adviser sold out of Sana Biotechnology (SANA) in Q2 2024, closing a stake of 52,459 shares — an estimated $525K sold.

Campbell & Co Investment Adviser first reported a position in SANA in Q1 2024 and held it in 1 quarter. The position peaked at $525K in Q1 2024. 147 funds tracked by Wall St. Rank hold SANA as of Q2 2024.

  • Campbell & Co Investment Adviser reported no remaining Sana Biotechnology position as of Q2 2024 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 52,459 Sana Biotechnology shares in Q2 2024, an estimated $525K.
  • Campbell & Co Investment Adviser first reported a position in Sana Biotechnology in Q1 2024 and held it in 1 quarter.
  • Campbell & Co Investment Adviser's Sana Biotechnology position peaked at $525K in Q1 2024.
  • 147 funds tracked by Wall St. Rank held Sana Biotechnology as of Q2 2024.

Based on Campbell & Co Investment Adviser's 13F filing for Q2 2024, filed 13 Aug 2024.